Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (2.187)

1

Lung toxicity induced by anti-HER2 antibody - drug conjugates for breast cancer

enthalten in: Critical reviews in oncology/hematology | 2024

von Chai, M. | Li, L. | Wu, H. | +3

2

Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapy

enthalten in: Transfusion | 2023

von Singh, N. | Staves, J. | Storry, J. | +6

3

Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer

enthalten in: The oncologist | 2023

von Kasi, P. | Afable, M. | Herting, C. | +2

4

Overcoming the hurdles : surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer

enthalten in: Clinical advances in hematology & oncology : H&O | 2023

von Sackstein, P. | Chintapally, N. | Wilgucki, M. | +3

5

Pembrolizumab in mCRPC - Combination therapies as breakthrough to success?

enthalten in: Current opinion in urology | 2023

von Plas, S. | Pircher, A. | Heidegger, I.

6

Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer

enthalten in: Clinical breast cancer | 2023

von Graff, S. | Yan, F. | Abdou, Y.

7

Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers

enthalten in: International immunopharmacology | 2023

von Wu, X. | Huang, S. | He, W. | +1

8

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Chu, E. | Wu, J. | Kang, S. | +1

9

Retifanlimab : First Approval

enthalten in: Drugs | 2023

von Kang, C.

10

A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer

enthalten in: The Annals of pharmacotherapy | 2023

von Heitz, N. | Greer, S. | Halford, Z.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[219]